Cite
HARVARD Citation
Shariati, L. et al. (2018). Disruption of SOX6 gene using CRISPR/Cas9 technology for gamma‐globin reactivation: An approach towards gene therapy of β‐thalassemia. Journal of cellular biochemistry. 119 (11), pp. 9357-9363. [Online].